Overview

Headlands Research runs a network of clinical trial sites across North America to support the development of new medicines. It provides research services to pharmaceutical and biotech companies by running and managing clinical trials, with a strong focus on recruiting and keeping diverse patient populations involved. What it does is coordinate and conduct trials at its sites, manage study logistics, and collect data so sponsors can evaluate safety and efficacy of therapies. Its differentiators include a large multinational network of sites, a dedicated emphasis on diverse and inclusive recruitment, and end-to-end trial management from site operations to data collection. The goal is to accelerate the development of new medical therapies by delivering high-quality, efficient, and inclusive clinical trials for sponsors.

Simplify's Take

What believers are saying

• THL's 2025 $600M acquisition fuels network expansion.
• Acquisitions like CMRCenter, Pharmasite add high-demand expertise.
• Sahara partnership boosts psychiatric trial accessibility.

What critics are saying

• THL's $600M debt crushes margins amid slowing demand.
• IQVIA acquisitions divert 20-30% pharma trials.
• FDA 2026 mandate slashes fixed-site enrollment 40%.

What makes Headlands Research unique

• Headlands operates 22 sites across US, Canada, Puerto Rico.
• Focuses on diverse patient recruitment via physician partnerships.
• Specializes in psychiatry, neurology, metabolic, device trials.

Help us improve and share your feedback! Did you find this helpful?

YesNo